ATE526022T1 - Stabilisierte zusammenstellungen die benzimidazole enthalten - Google Patents
Stabilisierte zusammenstellungen die benzimidazole enthaltenInfo
- Publication number
- ATE526022T1 ATE526022T1 AT99913726T AT99913726T ATE526022T1 AT E526022 T1 ATE526022 T1 AT E526022T1 AT 99913726 T AT99913726 T AT 99913726T AT 99913726 T AT99913726 T AT 99913726T AT E526022 T1 ATE526022 T1 AT E526022T1
- Authority
- AT
- Austria
- Prior art keywords
- compositions containing
- stabilized compositions
- benzimidazole
- type compounds
- containing benzimidazoles
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
- A61K31/4427—Non condensed pyridines; Hydrogenated derivatives thereof containing further heterocyclic ring systems
- A61K31/4439—Non condensed pyridines; Hydrogenated derivatives thereof containing further heterocyclic ring systems containing a five-membered ring with nitrogen as a ring hetero atom, e.g. omeprazole
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
- A61K31/4164—1,3-Diazoles
- A61K31/4184—1,3-Diazoles condensed with carbocyclic rings, e.g. benzimidazoles
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/20—Pills, tablets, discs, rods
- A61K9/2004—Excipients; Inactive ingredients
- A61K9/2009—Inorganic compounds
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/20—Pills, tablets, discs, rods
- A61K9/2004—Excipients; Inactive ingredients
- A61K9/2013—Organic compounds, e.g. phospholipids, fats
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/20—Pills, tablets, discs, rods
- A61K9/2004—Excipients; Inactive ingredients
- A61K9/2013—Organic compounds, e.g. phospholipids, fats
- A61K9/2018—Sugars, or sugar alcohols, e.g. lactose, mannitol; Derivatives thereof, e.g. polysorbates
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/04—Drugs for disorders of the alimentary tract or the digestive system for ulcers, gastritis or reflux esophagitis, e.g. antacids, inhibitors of acid secretion, mucosal protectants
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
JP10928898 | 1998-04-20 | ||
PCT/JP1999/002098 WO1999053918A1 (fr) | 1998-04-20 | 1999-04-20 | Compositions stabilisees contenant des composes du type benzimidazole |
Publications (1)
Publication Number | Publication Date |
---|---|
ATE526022T1 true ATE526022T1 (de) | 2011-10-15 |
Family
ID=14506385
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
AT99913726T ATE526022T1 (de) | 1998-04-20 | 1999-04-20 | Stabilisierte zusammenstellungen die benzimidazole enthalten |
Country Status (8)
Country | Link |
---|---|
US (2) | US20020039597A1 (de) |
EP (1) | EP1004305B1 (de) |
KR (1) | KR100627614B1 (de) |
CN (1) | CN1141097C (de) |
AT (1) | ATE526022T1 (de) |
CA (1) | CA2298823C (de) |
ES (1) | ES2373864T3 (de) |
WO (1) | WO1999053918A1 (de) |
Families Citing this family (51)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US6489346B1 (en) | 1996-01-04 | 2002-12-03 | The Curators Of The University Of Missouri | Substituted benzimidazole dosage forms and method of using same |
US6699885B2 (en) | 1996-01-04 | 2004-03-02 | The Curators Of The University Of Missouri | Substituted benzimidazole dosage forms and methods of using same |
US6645988B2 (en) | 1996-01-04 | 2003-11-11 | Curators Of The University Of Missouri | Substituted benzimidazole dosage forms and method of using same |
US5840737A (en) | 1996-01-04 | 1998-11-24 | The Curators Of The University Of Missouri | Omeprazole solution and method for using same |
EP1004305B1 (de) * | 1998-04-20 | 2011-09-28 | Eisai R&D Management Co., Ltd. | Stabilisierte zusammenstellungen die benzimidazole enthalten |
IL130602A0 (en) * | 1999-06-22 | 2000-06-01 | Dexcel Ltd | Stable benzimidazole formulation |
JP2003504338A (ja) * | 1999-07-12 | 2003-02-04 | スミスクライン・ビーチャム・コーポレイション | 胸やけの処置法 |
CA2387746C (en) | 1999-10-20 | 2010-06-29 | Koji Ukai | Methods for stabilizing benzimidazole-based compounds |
CA2419067C (en) | 2000-08-18 | 2008-12-23 | Takeda Chemical Industries, Ltd. | Injectable composition comprising benzimidazole compound and strong alkali |
AU2001211213A1 (en) * | 2000-10-20 | 2002-04-29 | Galephar M/F | Stable oral formulation containing benzimidazole derivative |
AR036354A1 (es) * | 2001-08-31 | 2004-09-01 | Takeda Chemical Industries Ltd | Preparacion solida |
ES2426723T3 (es) * | 2001-10-17 | 2013-10-24 | Takeda Pharmaceutical Company Limited | Gránulos que contienen gran cantidad de compuesto químico inestable en medio ácido |
UA76256C2 (en) * | 2001-11-21 | 2006-07-17 | Eisai Co Ltd | Composition containing acid-unstable physiologically active compound and process for its preparation |
WO2003051355A1 (fr) * | 2001-12-19 | 2003-06-26 | Takeda Chemical Industries, Ltd. | Compositions solides refermant des composes instables a l'oxygene et procede de stabilisation de ces composes |
CA2771725C (en) * | 2002-10-16 | 2015-08-18 | Takeda Pharmaceutical Company Limited | Solid preparation comprising a non-toxic base and a proton pump inhibitor |
MY148805A (en) | 2002-10-16 | 2013-05-31 | Takeda Pharmaceutical | Controlled release preparation |
US20050220870A1 (en) * | 2003-02-20 | 2005-10-06 | Bonnie Hepburn | Novel formulation, omeprazole antacid complex-immediate release for rapid and sustained suppression of gastric acid |
CA2517005A1 (en) * | 2003-02-20 | 2004-09-02 | Santarus, Inc. | A novel formulation, omeprazole antacid complex-immediate release for rapid and sustained suppression of gastric acid |
WO2004075881A1 (en) * | 2003-02-28 | 2004-09-10 | Ranbaxy Laboratories Limited | Stable pharmaceutical composition of rabeprazole and processes for their preparation |
KR100622638B1 (ko) * | 2003-04-04 | 2006-09-18 | 주식회사 씨트리 | 우수한 안정성을 갖는 란소프라졸 함유 약제학적 조성물및 이의 경구용 제제 |
RU2375048C2 (ru) * | 2003-07-17 | 2009-12-10 | Д-Р Редди'С Лабораторис Инк. | Фармацевтическая композиция с набухающим покрытием |
AR045062A1 (es) * | 2003-07-18 | 2005-10-12 | Santarus Inc | Formulaciones farmaceuticas para inhibir la secrecion de acido y metodos para preparar y utilizarlas |
US8993599B2 (en) | 2003-07-18 | 2015-03-31 | Santarus, Inc. | Pharmaceutical formulations useful for inhibiting acid secretion and methods for making and using them |
MXPA06000524A (es) * | 2003-07-18 | 2006-08-11 | Santarus Inc | Formulacion farmaceutica y metodo para tratar desordenes gastrointestinales provocados por acido. |
US20060165793A1 (en) * | 2003-08-04 | 2006-07-27 | Koji Ukai | Pharmaceutical preparation to be dispersed before administration |
TWI372066B (en) * | 2003-10-01 | 2012-09-11 | Wyeth Corp | Pantoprazole multiparticulate formulations |
US20070292498A1 (en) * | 2003-11-05 | 2007-12-20 | Warren Hall | Combinations of proton pump inhibitors, sleep aids, buffers and pain relievers |
CA2547398A1 (en) * | 2003-11-28 | 2005-06-09 | Ranbaxy Laboratories Limited | Oral benzimidazole compositions comprising an active core, an optional separating layer and an enteric coating |
WO2005076987A2 (en) * | 2004-02-10 | 2005-08-25 | Santarus, Inc. | Combination of proton pump inhibitor, buffering agent, and nonsteroidal anti-inflammatory agent |
CA2561700A1 (en) * | 2004-04-16 | 2005-12-15 | Santarus, Inc. | Combination of proton pump inhibitor, buffering agent, and prokinetic agent |
US8906940B2 (en) | 2004-05-25 | 2014-12-09 | Santarus, Inc. | Pharmaceutical formulations useful for inhibiting acid secretion and methods for making and using them |
US8815916B2 (en) | 2004-05-25 | 2014-08-26 | Santarus, Inc. | Pharmaceutical formulations useful for inhibiting acid secretion and methods for making and using them |
WO2006105798A2 (en) * | 2005-07-11 | 2006-10-12 | Nycomed Danmark Aps | Benzimidazole formulation |
EP1801110A1 (de) | 2005-12-22 | 2007-06-27 | KRKA, tovarna zdravil, d.d., Novo mesto | Argininsalz des Esomeprazols |
EP1872778A1 (de) * | 2006-06-29 | 2008-01-02 | LEK Pharmaceuticals D.D. | Stabile pharmazeutische Formulierung enthaltend Rabeprazol-Natrium |
US20090092658A1 (en) * | 2007-10-05 | 2009-04-09 | Santarus, Inc. | Novel formulations of proton pump inhibitors and methods of using these formulations |
WO2008129517A2 (en) * | 2007-04-23 | 2008-10-30 | Ranbaxy Laboratories Limited | A stabilized delayed release pharmaceutical composition of rabeprazole |
EP2293782B1 (de) * | 2008-05-06 | 2015-08-12 | Dexcel Pharma Technologies Ltd. | Stabile benzimidazolformulierung |
CN102186474A (zh) * | 2008-08-14 | 2011-09-14 | 杏林制药株式会社 | 稳定的医药组合物 |
KR101328383B1 (ko) * | 2009-08-27 | 2013-11-13 | 한림제약(주) | 유럽종 포도의 씨 추출물을 함유하는 경구용 정제 |
SI3158991T1 (sl) | 2010-01-28 | 2021-10-29 | Eagle Pharmaceuticals Inc | Formulacije bendamustina |
ES2943668T3 (es) | 2012-03-20 | 2023-06-15 | Eagle Pharmaceuticals Inc | Composiciones líquidas de bendamustina para su uso en un método para tratar afecciones que responden a la bendamustina en pacientes que requieren volúmenes reducidos para administración |
FI2827862T3 (fi) | 2012-03-20 | 2024-02-13 | Eagle Pharmaceuticals Inc | Bendamustiinin formulaatioita |
CN105641702A (zh) * | 2012-04-18 | 2016-06-08 | 中国人民解放军军事医学科学院毒物药物研究所 | 一种雷贝拉唑钠的药用组合物及其制备方法 |
US20170042806A1 (en) | 2015-04-29 | 2017-02-16 | Dexcel Pharma Technologies Ltd. | Orally disintegrating compositions |
WO2017065623A1 (en) * | 2015-10-16 | 2017-04-20 | Mendoza Wendell | Stable composition of vitamin c and zinc tablet |
US10736855B2 (en) | 2016-02-25 | 2020-08-11 | Dexcel Pharma Technologies Ltd. | Compositions comprising proton pump inhibitors |
US10730752B2 (en) | 2016-05-03 | 2020-08-04 | Virginia Commonwealth University | Heteroatom-doped porous carbons for clean energy applications and methods for their synthesis |
US10076494B2 (en) | 2016-06-16 | 2018-09-18 | Dexcel Pharma Technologies Ltd. | Stable orally disintegrating pharmaceutical compositions |
CA3067162A1 (en) | 2017-06-12 | 2018-12-20 | Glytech Llc. | Treatment of depression with nmda antagonists and d2/5ht2a or selective 5ht2a antagonists |
KR102315140B1 (ko) * | 2020-01-15 | 2021-10-20 | 주식회사 휴메딕스 | 알지닌 아스파테이트를 포함하는 노인성 체취 억제용 조성물 |
Family Cites Families (27)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CA1327010C (en) * | 1986-02-13 | 1994-02-15 | Tadashi Makino | Stabilized solid pharmaceutical composition containing antiulcer benzimidazole compound and its production |
GB2189698A (en) * | 1986-04-30 | 1987-11-04 | Haessle Ab | Coated omeprazole tablets |
SE8804629D0 (sv) * | 1988-12-22 | 1988-12-22 | Ab Haessle | New therapeutically active compounds |
YU48263B (sh) | 1991-06-17 | 1997-09-30 | Byk Gulden Lomberg Chemische Fabrik Gmbh. | Postupak za dobijanje farmaceutskog preparata na bazi pantoprazola |
SE9301830D0 (sv) * | 1993-05-28 | 1993-05-28 | Ab Astra | New compounds |
SE9302395D0 (sv) * | 1993-07-09 | 1993-07-09 | Ab Astra | New pharmaceutical formulation |
EE03305B1 (et) * | 1994-07-08 | 2000-12-15 | Astra Aktiebolag | Paljuosaline tableteeritud annusvorm I |
ES2094694B1 (es) * | 1995-02-01 | 1997-12-16 | Esteve Quimica Sa | Nueva formulacion farmaceuticamente estable de un compuesto de bencimidazol y su proceso de obtencion. |
SE9500478D0 (sv) | 1995-02-09 | 1995-02-09 | Astra Ab | New pharmaceutical formulation and process |
US5708017A (en) * | 1995-04-04 | 1998-01-13 | Merck & Co., Inc. | Stable, ready-to-use pharmaceutical paste composition containing proton pump inhibitors |
US5824339A (en) * | 1995-09-08 | 1998-10-20 | Takeda Chemical Industries, Ltd | Effervescent composition and its production |
BE1009764A3 (nl) * | 1995-11-06 | 1997-08-05 | Dsm Nv | Werkwijze voor de bereiding van een alpha-alkylkaneelaldehyde. |
US6645988B2 (en) * | 1996-01-04 | 2003-11-11 | Curators Of The University Of Missouri | Substituted benzimidazole dosage forms and method of using same |
DE19600347A1 (de) * | 1996-01-08 | 1997-07-10 | Lohmann Therapie Syst Lts | Hauthaftende pharmazeutische Zubereitung, insbesondere TTS zur Abgabe von 17-beta-Estradiol an den menschlichen Organismus |
JPH09216817A (ja) | 1996-02-08 | 1997-08-19 | Amano Pharmaceut Co Ltd | 防湿性且つ易水崩壊性コーティング製剤 |
DE69713948D1 (de) * | 1996-04-23 | 2002-08-22 | Janssen Pharmaceutica Nv | Rasch-freisetzende pH-unabhängige feste Dosisformen enthaltend Cisaprid |
US5972381A (en) * | 1996-06-28 | 1999-10-26 | Schering Corporation | Solid solution of an antifungal agent with enhanced bioavailability |
SE9702000D0 (sv) * | 1997-05-28 | 1997-05-28 | Astra Ab | New pharmaceutical formulation |
US6296876B1 (en) * | 1997-10-06 | 2001-10-02 | Isa Odidi | Pharmaceutical formulations for acid labile substances |
US20050244497A1 (en) * | 1997-11-05 | 2005-11-03 | Wockhardt Limited | Delayed delivery system for acid-sensitive drugs |
DK173431B1 (da) * | 1998-03-20 | 2000-10-23 | Gea Farmaceutisk Fabrik As | Farmaceutisk formulering omfattende en 2-[[(2-pyridinyl)methyl]sulfinyl]benzimidazol med anti-ulcusaktivitet samt fremgangs |
EP1004305B1 (de) * | 1998-04-20 | 2011-09-28 | Eisai R&D Management Co., Ltd. | Stabilisierte zusammenstellungen die benzimidazole enthalten |
ZA9810765B (en) * | 1998-05-28 | 1999-08-06 | Ranbaxy Lab Ltd | Stable oral pharmaceutical composition containing a substituted pyridylsulfinyl benzimidazole. |
US6248363B1 (en) * | 1999-11-23 | 2001-06-19 | Lipocine, Inc. | Solid carriers for improved delivery of active ingredients in pharmaceutical compositions |
CA2387746C (en) * | 1999-10-20 | 2010-06-29 | Koji Ukai | Methods for stabilizing benzimidazole-based compounds |
US20040028737A1 (en) * | 2002-08-12 | 2004-02-12 | Kopran Research Laboratories Limited | Enteric coated stable oral pharmaceutical composition of acid unstable drug and process for preparing the same |
EP1802118A1 (de) * | 2005-12-23 | 2007-06-27 | Alcatel Lucent | Interaktives Beantwortungssystem für den Zugang für Anwender auf Daten |
-
1999
- 1999-04-20 EP EP99913726A patent/EP1004305B1/de not_active Expired - Lifetime
- 1999-04-20 CN CNB998007323A patent/CN1141097C/zh not_active Expired - Fee Related
- 1999-04-20 ES ES99913726T patent/ES2373864T3/es not_active Expired - Lifetime
- 1999-04-20 KR KR1019997012021A patent/KR100627614B1/ko not_active IP Right Cessation
- 1999-04-20 WO PCT/JP1999/002098 patent/WO1999053918A1/ja not_active Application Discontinuation
- 1999-04-20 CA CA2298823A patent/CA2298823C/en not_active Expired - Fee Related
- 1999-04-20 AT AT99913726T patent/ATE526022T1/de not_active IP Right Cessation
- 1999-04-20 US US09/462,633 patent/US20020039597A1/en not_active Abandoned
-
2004
- 2004-09-13 US US10/938,554 patent/US20050042285A1/en not_active Abandoned
Also Published As
Publication number | Publication date |
---|---|
CA2298823A1 (en) | 1999-10-28 |
KR20010013994A (ko) | 2001-02-26 |
CN1275079A (zh) | 2000-11-29 |
KR100627614B1 (ko) | 2006-09-25 |
CA2298823C (en) | 2011-06-07 |
WO1999053918A1 (fr) | 1999-10-28 |
ES2373864T3 (es) | 2012-02-09 |
CN1141097C (zh) | 2004-03-10 |
US20020039597A1 (en) | 2002-04-04 |
EP1004305A1 (de) | 2000-05-31 |
EP1004305A4 (de) | 2009-01-21 |
US20050042285A1 (en) | 2005-02-24 |
EP1004305B1 (de) | 2011-09-28 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
ATE526022T1 (de) | Stabilisierte zusammenstellungen die benzimidazole enthalten | |
CY1107506T1 (el) | Μεθοδος για σταθεροποιηση ενωσεων βενζιμιδαζολης | |
ATE342263T1 (de) | Salze von benzimidazol-derivaten und deren verwendung | |
CO5580776A2 (es) | Formulacion farmaceutica estable en solucion de oxaliplatino | |
TR200200579T2 (tr) | Amino-tirazolpiridin türevleri. | |
ATE219932T1 (de) | Neue feste dosisform enthaltend nanopartikelnaproxen | |
AR092374A2 (es) | Preparacion liofilizada de 5-difluorometoxi-2-[(3,4-dimetoxi-2-piridinil)metilsulfinil]-1h-bencimidazol (pantoprazol) | |
GB9801690D0 (en) | Therapeutic agents | |
BR0311261A (pt) | Composição lìquida aquosa branqueadora dos dentes, e, método para branquear os dentes | |
ES2097174T3 (es) | Derivados de la 2-ciclohexan-1-il amina. | |
DE69922703D1 (de) | Ureido-thiobuttersäurederivate als ppar-agonisten | |
ES2145557T3 (es) | Composiciones de ablandamiento del agua y composiciones detergentes. | |
ES2151150T3 (es) | Preparados transparentes de rapida liberacion, de analgesicos no esteroidales. | |
BR0109542A (pt) | Derivados de imidazopirina alquilados | |
BR0107628A (pt) | l,2-diarilbenzimidazóis para tratamento de doenças que estão associadas a uma ativação microglial | |
DK1104289T3 (da) | Hidtil ukendte orale formuleringer for 5-HT4-agonister eller -antagonister | |
TR200001452T2 (tr) | Bifenilamidin türevleri. | |
BR0113062A (pt) | Derivados de heterociclilalquilazol e seu emprego como agente para o combate de parasitas | |
ATE302004T1 (de) | Stabile orale zusammensetzung enthaltend benzimidazol derivate | |
TR200001909T2 (tr) | Matris metaloprotez inhibitörleri. | |
ATE549947T1 (de) | Zigarettenfilter | |
HK1054738A1 (en) | (P-amino-hydroxyphenyl)-acrylamide derivatives an d dyes containing said compounds | |
TR200001121T2 (tr) | Antiromatizmal madde. | |
EA200101150A1 (ru) | Раствор прукалоприда для перорального применения | |
BR9812385A (pt) | Formulações parasiticidas |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
RER | Ceased as to paragraph 5 lit. 3 law introducing patent treaties |